Patients with major depressive disorder (MDD) treated with the anticonvulsant ezogabine demonstrated a significant drop in depressive symptoms and an increase in resilience in a small trial described online in Molecular Psychiatry.READ MORE
Use the links below to see all of our coverage of sessions, speakers, and posters at Psych Congress 2018.READ MORE
Adding mirtazapine to a serotonin-noradrenaline reuptake inhibitor or selective serotonin reuptake inhibitor for treatment-resistant depression is no more effective than adding placebo, according to a study.READ MORE
Steering Committee members discuss their favorite sessions and aspects of the 31st annual Psych Congress conference, held Oct. 25-28 in Orlando, Fla.READ MORE
Psych Congress Year-Round
ORLANDO, Fla.—Delivering a borderline personality disorder (BPD) diagnosis can feel tricky, leaving some clinicians afraid of sparking negative reactions and wondering if they should tell patients at all.
ORLANDO, Fla.—A friendly debate between 2 thought leaders followed by a vote at Psych Congress 2018 exhibited the divide that persists on a controversial topic in mental health: whether antidepressants should be used to treat patients with bipolar depression.